Please assess the completion status of the following clinical trial:

Trial Title: Impact of Auricular Vagus Nerve Neuromodulation on COVID-19 Positive Inpatients Outcome

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* COVID-19 positive inpatient (PCR or other certified test mandatory)~* Inpatient showing at least one of the following criterion: Abnormal respiratory auscultation AND SpO2 \< 94% without oxygen therapy, OR Acute Respiratory failure requiring either oxygen therapy or high-flow oxygen therapy or non-invasive respirator and/or invasive respirator.~Exclusion Criteria:~* Inpatient requiring legal protection~* Pregnant or breastfeeding woman~* Intensive care inpatient or patient undergoing surgery~Secondary non inclusion criteria :~- Unintentional blinding removal.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Auricular neuromodulation (Type: EXPERIMENTAL): None
- Control (Type: SHAM_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).